Carregant...
Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas
The BRAF(V600E) mutation, which in melanoma is targetable with vemurafenib, is also found in sarcomas and we here evaluate the therapeutic potential in sarcoma cell lines. Methods: Four sarcoma cell lines harboring the BRAF(V600E) mutation, representing liposarcomas (SA-4 and SW872), Ewing sarcoma (...
Guardat en:
| Publicat a: | Int J Mol Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5979358/ https://ncbi.nlm.nih.gov/pubmed/29570692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19040969 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|